Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
Landec Corporation (Nasdaq: LNDC) announced a change to its fiscal 2023 first quarter earnings conference call date, now set for October 6, 2022, due to Yom Kippur. The company will release financial results before the market opens, with a conference call at 8:00 AM ET. Lifecore Biomedical, Landec's CDMO, specializes in developing and manufacturing complex sterile injectable pharmaceutical products. A replay of the call will be available until October 13, 2022. For more details, visit their website.
- None.
- None.
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced a change to its previously announced fiscal 2023 first quarter earnings conference call date in recognition of Yom Kippur.
The Company will now report financial results before the market opens on Thursday, October 6, 2022 and hold a conference call to discuss the business update at 8:00 am ET/7:00 am CT that day. The live webcast can be accessed via Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days.
Date: Thursday, October 6, 2022
Time: 8:00 a.m. Eastern time (7:00 a.m. Central time)
Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1571075&tp_key=1996ac9554
To participate in the conference call via telephone, dial toll-free: 1-877-407-3982 (U.S.) or 1-201-493-6780 (International). Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.
A replay of the call will be available through October 13th, by calling toll-free: 1-844-512-2921 (U.S.) or 1-412-317-6671 (International), and entering code 13732915.
About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with
Landec Corp. Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com
FAQ
When will Landec Corporation announce its fiscal 2023 first quarter earnings?
What time is the Landec Corporation conference call for earnings?
How can I access the Landec Corporation earnings webcast?
What is the importance of Lifecore Biomedical for Landec Corporation?
